|
Biorestorative Therapies, Inc. (BRTX) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
BioRestorative Therapies, Inc. (BRTX) Bundle
¡Simplifique la valoración de Biorestorative Therapies, Inc. (BRTX) con esta calculadora DCF personalizable! Con Real Biorestorative Therapies, Inc. (BRTX) financieras y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Biorestorative Therapies, Inc. (BRTX) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .1 | .1 | .0 | .1 | .1 | .2 | .2 | .2 | .2 | .2 |
| Revenue Growth, % | 0 | -40.77 | -40.26 | 160.43 | 21.7 | 10.17 | 10.17 | 10.17 | 10.17 | 10.17 |
| EBITDA | -9.3 | -9.5 | -26.2 | -18.9 | -15.1 | -.2 | -.2 | -.2 | -.2 | -.2 |
| EBITDA, % | -7147.23 | -12312.44 | -56997.32 | -15737.46 | -10325.82 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .2 | .2 | .2 | .1 | .2 | .2 | .2 | .2 | .2 | .2 |
| Depreciation, % | 167.27 | 197.35 | 446.1 | 100.62 | 113.67 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -9.5 | -9.6 | -26.4 | -19.0 | -15.2 | -.2 | -.2 | -.2 | -.2 | -.2 |
| EBIT, % | -7314.5 | -12509.79 | -57443.41 | -15838.08 | -10439.49 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | .0 | 3.1 | 21.0 | 14.7 | 11.1 | .1 | .1 | .2 | .2 | .2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 24.62 | 22.08 | 10.87 | 13.36 | 13.24 | 16.83 | 16.83 | 16.83 | 16.83 | 16.83 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0.0012987 | 0 | 0.000834724541 | 0 | 0.000426685168 | 0.000426685168 | 0.000426685168 | 0.000426685168 | 0.000426685168 |
| Accounts Payable | 2.0 | .1 | .1 | .2 | .2 | .2 | .2 | .2 | .2 | .2 |
| Accounts Payable, % | 1503.41 | 154.35 | 110.49 | 142.66 | 129.9 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | -.4 | -.2 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | -27.41 | 0 | -66.65 | -367.46 | -117.31 | -58.81 | -58.81 | -58.81 | -58.81 | -58.81 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -11.6 | -10.5 | -17.9 | -18.5 | -15.2 | -.1 | -.2 | -.2 | -.2 | -.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -9.5 | -12.1 | -17.7 | -18.7 | -15.2 | -.1 | -.1 | -.1 | -.1 | -.1 |
| WACC, % | 5.69 | 5.69 | 5.65 | 5.68 | 5.69 | 5.68 | 5.68 | 5.68 | 5.68 | 5.68 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -3 | |||||||||
| Present Terminal Value | -2 | |||||||||
| Enterprise Value | -3 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -0.45 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: BioRestorative Therapies, Inc. (BRTX) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
- Customizable and Professional: A refined Excel model that adjusts to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Customizable Treatment Parameters: Adjust key metrics such as patient outcomes, treatment costs, and recovery times.
- Instant Clinical Evaluation: Provides immediate assessments of treatment effectiveness and potential benefits.
- High-Precision Results: Utilizes real-world data from BioRestorative Therapies, Inc. (BRTX) for accurate analysis.
- Streamlined Scenario Testing: Easily explore various treatment options and assess their impacts.
- Efficiency Booster: Remove the complexity of developing intricate treatment models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based BRTX Valuation Model.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth projections, discount rates, profit margins, and more.
- Instant Calculations: The model automatically recalculates the intrinsic value of BioRestorative Therapies, Inc. (BRTX).
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the findings to inform your investment or financial strategy.
Why Choose BioRestorative Therapies, Inc. (BRTX)?
- Innovation: Cutting-edge therapies backed by extensive research and development.
- Expertise: Team of professionals with deep knowledge in regenerative medicine.
- Accessibility: Solutions designed to be user-friendly for both practitioners and patients.
- Commitment: Dedicated to improving patient outcomes through advanced biotechnologies.
- Trustworthiness: Transparent operations and adherence to regulatory standards.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for assessing biotechnology investments.
- Corporate Development Teams: Evaluate valuation scenarios to inform strategic decisions within the biotech sector.
- Consultants and Advisors: Deliver precise valuation insights for BioRestorative Therapies, Inc. (BRTX) to clients.
- Students and Educators: Utilize real-world biotech data to enhance learning and financial modeling skills.
- Biotech Enthusiasts: Gain insights into the valuation processes of innovative companies like BioRestorative Therapies, Inc. (BRTX).
What the Template Contains
- Historical Data: Includes BioRestorative Therapies, Inc.'s (BRTX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate BioRestorative Therapies, Inc.'s (BRTX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of BioRestorative Therapies, Inc.'s (BRTX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.